Sun Pharmaceutical Industries Ltd share price
Sun Pharmaceutical Industries Ltd (SUNPHARMA) is a stock listed on India's exchanges (NSE & BSE). It is commonly tracked under the Pharma theme. As of the latest filings, Sun Pharmaceutical Industries Ltd has a return on equity (ROE) of 16.00%, return on capital employed (ROCE) of 20.50%, a price-to-earnings (P/E) ratio of 34.70 and a debt-to-equity ratio of 0.04. On Traddx you can view its live price, interactive candlestick charts with 20/50/200-day moving averages and golden/death-cross detection, quarterly results, analyst price targets, peer comparison, and the smart-money signal — which star investors hold it and who is buying it on today's bulk/block deals tape.
Key fundamentals
Source: screener.in (NSE/BSE filings) · Fundamentals as of 01 Nov 2026 · figures from the latest annual & quarterly filings. Not investment advice.
Sun Pharmaceutical Industries Limited value chain — customers, suppliers & competitors
Sun Pharmaceutical Industries Limited is India's largest pharmaceutical company, manufacturing and marketing branded and generic medicines, specialized formulations, and active pharmaceutical ingredients (APIs) globally.
🛒 Customers — who buys from Sun Pharmaceutical Industries Limited
- Global Distributors and Wholesalers — Generic and branded pharmaceutical formulations
- Hospitals and Healthcare Institutions — Specialty medicines and injectables
⛓️ Suppliers — raw materials & inputs
- Chemical and Solvent Manufacturers — Basic organic chemicals and chemical intermediates
- Active Pharmaceutical Ingredient (API) Suppliers — Specialized raw drug powders
- Packaging Material Suppliers — Aluminium foils, blister packs, and cartons
⚔️ Competitors — other sellers
- Dr. Reddy's Laboratories — Competes globally in generic drugs and US market share; Dr. Reddy's is smaller in overall market capitalization.
- Cipla — Competes strongly in the domestic formulations market and respiratory segment.
- Lupin — Competes in global generics, particularly in the US and India formulations.
🔀 Other suppliers to its customers
- Dr. Reddy's Laboratories — Provides alternative generic drug portfolios to the same global pharmacy chains.
- Cipla — Supplies competing generic and branded formulations to distributors.
- Lupin — Offers similar generic substitute drugs to institutional and retail buyers.
🤝 Peers that share its suppliers
- Dr. Reddy's Laboratories — Buys similar chemical intermediates and packaging materials from shared vendor networks.
- Cipla — Sources common chemical raw materials and machinery from overlapping industry suppliers.
This value-chain map is AI-researched from public sources; company links and any figures are estimates, not official company disclosures. Not investment advice.